AH
Akso Health Group
AHG · NASDAQ
$0.75 -2.30% (-$0.02)
1M -19.19%
Market Cap $640.5M
P/E Ratio -
Div. Yield -
ROE 9.84%
Bulios Fair Price
$1.09
45.1% upside
Current Price
$0.75
Undervalued Fair Value Overvalued
According to Bulios Fair Price, AHG is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
3/9Valuation
29 /100
Expensive P/B 3.54x
P/S 46.31x
P/FFO N/A
Growth
44 /100
Stable Book val. growth 174.73%
Rev. growth 1.62%
FCF growth N/A
Profitability
0 /100
Weak Net margin 134.99%
Op. margin 28.92%
FCF margin 1,362.48%
Quality
1 /100
Poor ROE 9.84%
ROA 9.85%
Asset turnover 0.07x
Debt
100 /100
Low Current ratio 21.77x
Debt/Equity 0.00x
Net debt/EBITDA N/A
Stability
13 /100
Unstable Rev. volatility 323.28%
EPS volatility 342.96%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about AHG
Online
Sector
Healthcare
Industry
Medical - Distribution
CEO
Yilin Wang
Employees
12
Headquarters
Qingdao
Upcoming events
02 DEC
Earnings
Upcoming earnings report